Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BellBrook Labs
Madison, Wisconsin, United Statesbellbrooklabs.com ↗
- Ownership
- Private
- Employees
- ~18
- Development stage
- Other
01
Overview
BellBrook Labs develops high throughput screening assay platforms—primarily the Transcreener® technology—to accelerate enzyme-targeted drug discovery. Their products are widely adopted by major pharmaceutical companies to streamline lead identification and optimization. They do not have clinical results as they do not develop drugs directly.
- Modalities
- Small moleculeBiologicEnzyme assay
- Industry
- Drug Discovery Services
Beyond the preview
Go deeper on BellBrook Labs.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BellBrook Labs.